ATTACHMENT C
ANTIPSYCHOTIC AGENTS
MONITORING PROTOCOL1 FOR PATIENTS ON SGAs*
Baseline
4
Weeks
8
Weeks
12
Weeks
x
Personal family history
x
x
x
x
Weight (BMI)
x
Waist Circumference
x
x
Blood Pressure
x
x
Fasting Plasma Glucose
x
x
Fasting Lipid Profile
*More frequent assessments may be warranted based on clinical status.
1
Quarterly Annually
Every 5
Years
x
x
x
x
x
x
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care.
February 2004. 27 (2): 596-601.
Effective 10/03/11